SAN DIEGO--(BUSINESS WIRE)--March 6, 2006--Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company focused on therapies for gastrointestinal (GI) diseases and disorders, today reported financial and operating results for the quarter and year ended December 31, 2005.
